New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
10:03 EDTNLNK, XOMA, BIG, PANW, SWYOptions with decreasing implied volatility: NLNK XOMA BIG PANW SWY
News For NLNK;XOMA;BIG;PANW;SWY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 22, 2014
12:19 EDTNLNKOptions with decreasing implied volatility
Subscribe for More Information
06:44 EDTPANWU.S. weighing cybersecurity requirements for bank vendors, NY Times says
Subscribe for More Information
06:41 EDTNLNKWHO fast-tracking testing of two Ebola vaccines, Guardian reports
Subscribe for More Information
October 21, 2014
07:30 EDTPANWPalo Alto price target raised to $115 from $100 at Oppenheimer
Oppenheimer raised its price target for Palo Alto Networks shares to $115 after meeting with management and reiterates an Outperform rating on the stock. The firm thinks shares can continue to move higher as the company's fundamentals remain intact.
06:52 EDTNLNKNewLink Genetics price target raised to $41 from $34 at Cantor
Subscribe for More Information
October 20, 2014
12:37 EDTNLNKOn The Fly: Midday Wrap
Subscribe for More Information
10:50 EDTNLNKCanada ships experimental Ebola vaccine licensed to NewLink to WHO
The Government of Canada announced over this weakened that it will ship 800 vials of its experimental Ebola vaccine to the World Health Organization, or WHO, in Geneva, beginning with its first shipment on Monday, October 20. The Public Health Agency of Canada is supplying the vaccine to the WHO in its role as the international coordinating body for the Ebola outbreak, so that the vaccine can be made available as an international resource, Canada stated. This experimental Ebola vaccine has just begun clinical trials in humans, after showing very promising results in animal research and the Government of Canada has licensed the rights to NewLink Genetics through its wholly owned subsidiary BioProtection Systems to further develop the product for use in humans. Reference Link
10:38 EDTNLNKHigh option volume stocks
Subscribe for More Information
09:34 EDTNLNKNewLink Genetics deal validates inhibitor program, says Mizuho
Subscribe for More Information
09:22 EDTNLNKOn The Fly: Pre-market Movers
Subscribe for More Information
09:09 EDTNLNKEMA encourages applications for orphan designation for Ebola treatments
The European Medicines Agency encourages developers of treatments or vaccines against Ebola to apply for orphan designation. Applications for orphan designation of Ebola medicines will be treated as a priority and EMA has committed to fast-tracking their evaluation, the regulator announced. Drug companies that are working on experimental Ebola vaccines and treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX), NewLink Genetics (NLNK) and GlaxoSmithKline (GSK).
07:16 EDTXOMAAmerican Academy of Ophthalmology to hold annual meeting
AAO Annual Meeting 2014 is being held in Chicago on October 18-21.
07:06 EDTNLNKNewLink announces worldwide license agreement for NLG919 development
Subscribe for More Information
October 19, 2014
16:44 EDTNLNKEbola drug discovery efforts intensify, WSJ says
Subscribe for More Information
13:39 EDTNLNKCarnival cruise passenger tests negative for Ebola, Reuters says
Subscribe for More Information
October 17, 2014
14:50 EDTNLNKBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
11:17 EDTNLNKGSK says Ebola vaccine too late for current epidemic, BBC reports
Subscribe for More Information
10:00 EDTBIGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:46 EDTNLNKSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
08:11 EDTBIGBig Lots initiated with a Buy at Stifel
Target $58.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use